Your Search Returned 268 tagged news reports
The Brazilian producer has sustained a longstanding relationship with the esteemed Cologne-based label for nearly a decade, which oversaw the release of his debut album Chromophobia back in 2007. His upcoming Abaporu LP (artwork above), is named for
The patent is expected to be issued during 2014 and will have a 2029 expiry date. RHB-104 is a proprietary antibiotic combination oral capsule formulation for the treatment of Crohn's disease, currently undergoing a Phase III study in the U.S.,
Lp-PLA2 inhibitor in adults following an acute coronary syndrome (ACS). In the study, darapladib did not achieve the primary endpoint of a reduction of major coronary events versus placebo when added to standard of care...Acute coronary syndrome is a
Phase III study was conducted in patients with metastatic pancreatic cancer who previously received gemcitabine-based therapy. The primary log-rank analysis of overall survival was statistically significant (p=0.012) with a corresponding hazard ratio
Published 20 March 2014 Collegium Pharmaceutical has announced that the US Patent Application No...As such, the claims cover multiple products in Collegium's development pipeline. Collegium's larger portfolio of US and international filings...The
The string of live performances will find the enduring DJ/producerwhose only original solo release since 2011's III LP was the "Too Late" b/w "We Can Go" 12" from last year making stops in New York, Chicago, Montreal, Lisbon, Tel Aviv, Dublin, London,
Food and music have much in common, beyond energy and artistry. Each composition has flavor and texture, color, lightness, depth and subtlety...Colleagues at the schools are teaming with students from the Cleveland Institute of Music to create an
Nair's Dare To Dream (Imran Chisty up) won the Bhagyanagar Juvenile Million (1400m), the main event of the races here on Friday...II, 3-y-o only (Terms): Carlton (Beuzelin Louis) 1, Star Player (Deep Shanker) 2, Upon A Star (P...Owners: Mr. & Mrs.
Stadium Drive; $595,000; commercial Georgia Stillwell to Jeffery Stillwell; 5785 Exeter Court; $540,000 Richard Lingo to Taylor Collier; 6368 Rivermont Court; $485,000 Leary & Brown, Inc. to Lloyd and Dawn Steeves; 8008 Summit Court; $480,000;
Debiopharm is investigating the efficacy and safety of the gonadotropin releasing hormone (GnRH) agonist analog triptorelin pamoate six-month formulation in the treatment of children suffering from central (GnRH-dependent) precocious puberty (CPP).